|
2003 Journal Article Olanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New ZealandGureje, O, Miles, W, Keks, N, Grainger, D, Lambert, T, McGrath, J, Tran, P, Catts, S, Fraser, A, Hustig, H, Andersen, S and Crawford, AM (2003). Olanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New Zealand. Schizophrenia Research, 61 (2-3), 303-314. doi: 10.1016/S0920-9964(02)00226-8 |
|
2002 Journal Article Disturbed communication in schizophrenia: the role of poor pragmatics and poor mind-readingLangdon, R., Coltheart, M., Ward, P. B. and Catts, S. V. (2002). Disturbed communication in schizophrenia: the role of poor pragmatics and poor mind-reading. Psychological Medicine, 32 (7), 1273-1284. doi: 10.1017/S0033291702006396 |
|
2002 Journal Article Working with groups in early psychosisCatts, SV (2002). Working with groups in early psychosis. Australian and New Zealand Journal of Psychiatry, 36 (3), 439-439. |
|
2000 Journal Article Schizotypy: phenotypic marker as risk factorCatts, SV, Fox, AM, Ward, PB and McConaghy, N (2000). Schizotypy: phenotypic marker as risk factor. Australian and New Zealand Journal of Psychiatry, 34 (2_suppl), S101-S107. doi: 10.1080/000486700229 |
|
2000 Journal Article Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene?Catts, VS and Catts, SV (2000). Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene?. Schizophrenia Research, 41 (3), 405-415. doi: 10.1016/S0920-9964(99)00077-8 |
|
1999 Journal Article Superior temporal gyral volumes and laterality correlates of auditory hallucinations in schizophreniaLevitan, C, Ward, PB and Catts, SV (1999). Superior temporal gyral volumes and laterality correlates of auditory hallucinations in schizophrenia. Biological Psychiatry, 46 (7), 955-962. doi: 10.1016/S0006-3223(98)00373-4 |
|
1999 Journal Article Changes in auditory selective attention and event-related potentials following oral administration of D-amphetamine in humansMcKetin, R, Ward, PB, Catts, SV, Mattick, RP and Bell, JR (1999). Changes in auditory selective attention and event-related potentials following oral administration of D-amphetamine in humans. Neuropsychopharmacology, 21 (3), 380-390. doi: 10.1016/S0893-133X(99)00017-2 |
|
1999 Journal Article Effects of prepulses and d-amphetamine on performance and event-related potential measures an an auditory discrimination taskKroner, S, Schall, U, Ward, PB, Sticht, G, Banger, MW, Haffner, HT and Catts, SV (1999). Effects of prepulses and d-amphetamine on performance and event-related potential measures an an auditory discrimination task. Psychopharmacology, 145 (2), 123-132. doi: 10.1007/s002130051040 |
|
1999 Journal Article Auditory event-related potential indices of fronto-temporal information processing in schizophrenia syndromes: valid outcome prediction of clozapine therapy in a three-year follow-upSchall, U, Catts, SV, Karayanidis, F and Ward, PB (1999). Auditory event-related potential indices of fronto-temporal information processing in schizophrenia syndromes: valid outcome prediction of clozapine therapy in a three-year follow-up. International Journal of Neuropsychopharmacology, 2 (2), 83-93. doi: 10.1017/S1461145799001418 |
|
1998 Journal Article The effect of clozapine therapy on frontal lobe dysfunction in schizophrenia: neuropsychology and event-related potential measuresSchall, U, Catts, SV, Chaturvedi, S, Liebert, B, Redenbach, J, Karayanidis, F and Ward, PB (1998). The effect of clozapine therapy on frontal lobe dysfunction in schizophrenia: neuropsychology and event-related potential measures. International Journal of Neuropsychopharmacology, 1 (1), 19-29. doi: 10.1017/S146114579800100X |
|
1998 Journal Article Risperidone versus haloperidol: I. Meta-analysis of efficacy and safetyDavies, A, Adena, MA, Keks, NA, Catts, SV, Lambert, T and Schweitzer, I (1998). Risperidone versus haloperidol: I. Meta-analysis of efficacy and safety. Clinical Therapeutics, 20 (1), 58-71. doi: 10.1016/S0149-2918(98)80034-9 |
|
1998 Journal Article Interleukin-2 and schizophrenia: ReplyO'Donnell, M, Catts, SV, Ward, PB, Liebert, B, Lloyd, A, Wakefield, D and McConaghy, N (1998). Interleukin-2 and schizophrenia: Reply. Psychiatry Research, 77 (1), 65-66. doi: 10.1016/S0165-1781(97)00130-3 |
|
1998 Journal Article Risperidone versus haloperidol: II. Cost-effectivenessDavies, A, Langley, PC, Keks, NA, Catts, SV, Lambert, T and Schweitzer, I (1998). Risperidone versus haloperidol: II. Cost-effectiveness. Clinical Therapeutics, 20 (1), 196-213. doi: 10.1016/S0149-2918(98)80046-5 |
|
1997 Journal Article The effect of decreased catecholamine transmission on ERP indices of selective attentionShelley, AM, Catts, SV, Ward, PB, Andrews, S, Mitchell, P, Michie, P and McConaghy, N (1997). The effect of decreased catecholamine transmission on ERP indices of selective attention. Neuropsychopharmacology, 16 (3), 202-210. doi: 10.1016/S0893-133X(96)00190-X |
|
1997 Journal Article Molecular biological investigations into the role of the NMDA receptor in the pathophysiology of schizophreniaCatts, SV, Ward, PB, Lloyd, A, Huang, XF, Dixon, G, Chahl, L, Harper, C and Wakefield, D (1997). Molecular biological investigations into the role of the NMDA receptor in the pathophysiology of schizophrenia. Australian and New Zealand Journal of Psychiatry, 31 (1), 17-26. doi: 10.3109/00048679709073795 |
|
1997 Journal Article Molecular biology and the major psychosesLloyd, A, Dixon, G, Huang, XF, Ward, P, Catts, S, Hickie, I and Wakefield, D (1997). Molecular biology and the major psychoses. Australian and New Zealand Journal of Psychiatry, 31 (1), 12-16. doi: 10.3109/00048679709073794 |
|
1996 Journal Article Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorderODonnell, MC, Catts, SV, Ward, PB, Liebert, B, Lloyd, A, Wakefield, D and McConaghy, N (1996). Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder. Psychiatry Research, 65 (3), 171-178. doi: 10.1016/S0165-1781(96)02824-7 |
|
1996 Journal Article Replication of a P50 auditory gating deficit in Australian patients with schizophreniaWard, PB, Hoffer, LD, Liebert, BJ, Catts, SV, ODonnell, M and Adler, LE (1996). Replication of a P50 auditory gating deficit in Australian patients with schizophrenia. Psychiatry Research, 64 (2), 121-135. doi: 10.1016/0165-1781(96)02876-4 |
|
1996 Journal Article Predisposition toward auditory hallucinations: The utility of the Launay-Slade hallucination scale in psychiatric patientsLevitan, C, Ward, PB, Catts, SV and Hemsley, DR (1996). Predisposition toward auditory hallucinations: The utility of the Launay-Slade hallucination scale in psychiatric patients. Personality and Individual Differences, 21 (2), 287-289. doi: 10.1016/0191-8869(96)00052-9 |
|
1995 Journal Article Remoxipride versus thioridazine in the treatment of first episodes of schizophrenia in drug-naive patients: A case for specific, low potency D-2 antagonistsLambert, T., Keks, N., McGrath, J., Catts, S., Hustig, H., Vaddadi, K., Burrows, G., Varghese, F., George, T., Kerr, K., Johnson, G., Burnett, P., Zorbas, A., Hill, C. and Copolov, D. (1995). Remoxipride versus thioridazine in the treatment of first episodes of schizophrenia in drug-naive patients: A case for specific, low potency D-2 antagonists. Human Psychopharmacology, 10 (6), 455-460. doi: 10.1002/hup.470100604 |
